Comparison of 1 week versus 4 weeks of albendazole therapy in single small enhancing computed tomography lesion

Neurology India

Volumn 58, Issue 4, 2010, Pages 560-564

  Kaur, Prabhjeet ^a   Dhiman, Praveena ^a   Dhawan, Neeraj ^a   Nijhawan, Raman ^a   Pandit, Sadbhavna ^a  

^a Government Multispeciality Hospital   (India)

Author keywords

Albendazole; contrast enhanced computer tomography; duration; neurocysticercosis; single small enhancing computed tomographic lesions

Indexed keywords

ALBENDAZOLE; ANTICONVULSIVE AGENT; TUBULIN MODULATOR;

ARTICLE; BRAIN CALCIFICATION; BRAIN DAMAGE; CHILD; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG ERUPTION; DRUG HYPERSENSITIVITY; FEMALE; FOLLOW UP; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; SCHOOL CHILD; SEIZURE; SINGLE SMALL ENHANCING COMPUTED TOMOGRAPHIC LESION; STEVENS JOHNSON SYNDROME; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; DOUBLE BLIND PROCEDURE; INFANT; NONPARAMETRIC TEST; RETROSPECTIVE STUDY; SEIZURES; TIME;

ALBENDAZOLE; CHILD; CHILD, PRESCHOOL; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT; MALE; RETROSPECTIVE STUDIES; SEIZURES; STATISTICS, NONPARAMETRIC; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME; TUBULIN MODULATORS;

EID: 77956388770     PISSN: 00283886     EISSN: 19984022     Source Type: Journal    
DOI: 10.4103/0028-3886.68677     Document Type: Article

References (19)

1. Ito A, Nakao M, Wandra T. Human taeniasis cysticercosis in Asia. Lancet 2003;362:1918-1920
2. Garcia HH, Gonzalex AE, Evans CA, Gilman RH. Cysticercosis working group in Peru. Taenia Solium cysticercosis. Lancet 2003;362:547-556
3. Rajshekhar V, Joshi DD, Doanh NQ, van De N, Xiaonong Z. Taenia solium taeniasis/cysticercosis in Asia: epidemiology, impact and issues. Acta Trop 2003;87:53-60.
4. Rajshekhar V. Etiology and management of single small CT lesions in patients with seizures: understanding a controversy. Acta Neurol Scand 1991;84:465-470
5. Baranwal AK, Singhi PD, Khandelwal N, Singhi SC. Albendazole therapy in children with focal seizures and single small enhancing computerized tomographic lesions: a randomized, placebo-controlled, double blind trial. Pediatr Infect Dis J 1998;17:696-700.
6. Kalra V, Dua T, Kumar V. Efficacy of albendazole and short course dexamethasone treatment in children with 1 or 2 ring-enhancing lesions of neurocysticercosis: a randomized controlled trial. J Pediar 2003;143:111-114
7. Gracia HH, Pretell EJ, Gilman RH, Martinez SM, Moulton LH, Del Brutto OH, et al. A trial of antiparasitic treatment to reduce the rate of seizures due to cerebral cysticercosis. N Engl J Med 2004;350:249-258
8. Del Brutto OH, Roos KL, Coffey CS, Garcia HH. Meta analysis: cysticidal drugs for neurocysticercosis: albendazole and praziquantel. Ann Intern Med 2006;145:43-51.
9. Thussu A, Chattopadhyay A, Sawhney IM, Khandelwal N. Albendazole therapy for single small enhancing CT lesions (SSECTL) in the brain in epilepsy. J Neurol Neurosurg Psychiatry 2008;79:272-275
10. Sotelo J, Torres B, Rubio-Donnadieu F, Escobedo F, Rodriguez-Carbajal J. Praziquantel in treatment of neurocysticercosis: long term follow-up. Neurology 1985;35:752-754
11. Escobedo F, Penagos P, Rodriguez J, Sotelo J. Albendazole therapy for neurocysticercosis. Arch Intern Med 1987;147:738-741
12. Ahuja GK, Behari M, Prasad K, Goulatia RK, Jailkhani BL. Disappearing CT lesions in epilepsy: is tuberculosis or cysticercosis the cause? J Neurol Neurosurg Psychiatry 1989;52:915-916
13. Sethi PK, Kumar BR, Madan VS, Mohan V. Appearing and disappearing CT scan abnormalities and seizures. J Neurol Neurosurg Psychiatry 1985;48:866-869
14. Rajshekhar V. Solitary cerebral cysticercus granuloma. Epilepsia 2003;44 Suppl 1:25-28
15. Singhi P, Singhi S, Ramanathan R P, Bharti S. Neurocysticercosis in focal epilepsy in North India. Epilepsia 1995;36:156.
16. Sotelo J, Escobedo F, Penagos P. Albendazole versus praziquantel for therapy of neurocysticercosis: a controlled trial. Arch Neurol 1988;45:532-534
17. Singhi P, Singhi S. Neurocysticercosis in children. J Child Neurol 2004;19:482-492
18. Singhi P, Dayal D, Khandelwal N. One week versus four week of albendazole therapy for neurocysticercosis in children: a randomized, placebo-controlled double blind trial. Pediatr Infect Dis J 2003;22:268-272
19. Gogia S, Talukdar B, Chaudhury V, Arora BS. Neurocysticercosis in children:clinical findings and response to albendazole therapy in a randomized double blind, placebo controlled trial in newly diagnosed cases. Trans R Soc Trop Med Hyg 2003;97:416-422